These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19623715)

  • 1. [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo].
    Bondareva TA; Borisevich IV; Kalininskiĭ VB; Bondarev VP; Fomenkov OO
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):10-3. PubMed ID: 19623715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].
    Ryzhko IV; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2009; 54(5-6):37-40. PubMed ID: 20052916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
    Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluoroquinolones: antimicrobial activity and chemotherapeutic efficacy with respect to various pathogens in highly dangerous diseases].
    Bondareva TA; Kalininskiĭ VB; Borisevich IV; Bondarev VP; Kozhukhov VV; Amosov MIu; Baramzina GV; Fomenkov OO; Krinitsyn FV
    Antibiot Khimioter; 2007; 52(11-12):21-4. PubMed ID: 19275053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
    Naber KG; Hollauer K; Kirchbauer D; Witte W
    Int J Antimicrob Agents; 2000 Nov; 16(3):239-43. PubMed ID: 11091042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
    Yong DE; Cheong HJ; Kim YS; Park YJ; Kim WJ; Woo JH; Lee KW; Kang MW; Choo YS
    J Korean Med Sci; 2002 Dec; 17(6):737-42. PubMed ID: 12482994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments].
    Manzeniuk IN; Dorokhin VV; Svetoch EA
    Antibiot Khimioter; 1994; 39(2-3):26-30. PubMed ID: 7979790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of fluoroquinolones against pathogenic oral bacteria.
    Núñez Otero V; Limeres Posse J; Carmona IT; Diz Dios P
    Mini Rev Med Chem; 2009 Sep; 9(10):1147-58. PubMed ID: 19534690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
    Johnson JL; Hadad DJ; Boom WH; Daley CL; Peloquin CA; Eisenach KD; Jankus DD; Debanne SM; Charlebois ED; Maciel E; Palaci M; Dietze R
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):605-12. PubMed ID: 16776446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolones in the management of community-acquired pneumonia in primary care.
    Wispelwey B; Schafer KR
    Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
    Phillips ST; Nagaro K; Sambol SP; Johnson S; Gerding DN
    Anaerobe; 2011 Aug; 17(4):166-9. PubMed ID: 21511046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
    Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
    Hoepelman I
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2115-21. PubMed ID: 15553354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of treatment of experimental glanders after aerogenic infection].
    Iliukhin VI; Alekseev VV; Antonov IuV; Savchenko ST; Lozovaia NA
    Antibiot Khimioter; 1994; 39(9-10):45-8. PubMed ID: 7695450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
    García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
    Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
    Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders].
    Batmanov VP
    Antibiot Khimioter; 1991 Sep; 36(9):31-4. PubMed ID: 1781709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.